Arcadia Biosciences, Inc. Quarterly Current Ratio in % from Q3 2015 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Arcadia Biosciences, Inc. quarterly Current Ratio history and growth rate from Q3 2015 to Q3 2024.
  • Arcadia Biosciences, Inc. Current Ratio for the quarter ending September 30, 2024 was 433 %, a 26.5% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 433 -156 -26.5% Sep 30, 2024
Q2 2024 452 -192 -29.8% Jun 30, 2024
Q1 2024 484 -175 -26.5% Mar 31, 2024
Q4 2023 546 -111 -16.9% Dec 31, 2023
Q3 2023 589 -91.9 -13.5% Sep 30, 2023
Q2 2023 644 -23.6 -3.53% Jun 30, 2023
Q1 2023 659 -14.7 -2.18% Mar 31, 2023
Q4 2022 657 -96.2 -12.8% Dec 31, 2022
Q3 2022 681 -21 -2.98% Sep 30, 2022
Q2 2022 668 +94.8 +16.5% Jun 30, 2022
Q1 2022 674 +201 +42.6% Mar 31, 2022
Q4 2021 753 +398 +112% Dec 31, 2021
Q3 2021 702 +350 +99.6% Sep 30, 2021
Q2 2021 573 +141 +32.7% Jun 30, 2021
Q1 2021 472 -24.5 -4.92% Mar 31, 2021
Q4 2020 356 -189 -34.7% Dec 31, 2020
Q3 2020 352 -247 -41.3% Sep 30, 2020
Q2 2020 432 -267 -38.2% Jun 30, 2020
Q1 2020 497 -346 -41% Mar 31, 2020
Q4 2019 544 -317 -36.8% Dec 31, 2019
Q3 2019 599 -164 -21.5% Sep 30, 2019
Q2 2019 699 +4.27 +0.61% Jun 30, 2019
Q1 2019 843 +209 +32.9% Mar 31, 2019
Q4 2018 861 +140 +19.4% Dec 31, 2018
Q3 2018 763 -187 -19.7% Sep 30, 2018
Q2 2018 695 -393 -36.1% Jun 30, 2018
Q1 2018 634 -690 -52.1% Mar 31, 2018
Q4 2017 721 -705 -49.4% Dec 31, 2017
Q3 2017 950 -445 -31.9% Sep 30, 2017
Q2 2017 1.09K +37.3 +3.55% Jun 30, 2017
Q1 2017 1.32K +456 +52.6% Mar 31, 2017
Q4 2016 1.43K +843 +145% Dec 31, 2016
Q3 2016 1.4K +984 +239% Sep 30, 2016
Q2 2016 1.05K Jun 30, 2016
Q1 2016 868 Mar 31, 2016
Q4 2015 583 Dec 31, 2015
Q3 2015 412 Sep 30, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.